Royalty Pharma (RPRX) EBIT (2019 - 2026)
Royalty Pharma's EBIT was $133.12 million in Q2 2026, down 36.5% from $209.8 million a year earlier and down 76.4% from the prior quarter.
Powered by 
Analysis
Royalty Pharma (RPRX) EBIT (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Royalty Pharma's EBIT was $1.51 billion through Jun 30, 2026, down 17.9% year-over-year; for FY2025, it was $1.56 billion, up 20.7% from FY2024.
- EBIT shows a five-year compound annual growth rate of -0.5% (FY2020 to FY2025).
- In earlier years, EBIT was $1.29 billion in FY2024 (-13.4%), $1.49 billion in FY2023 (+385.9%), $307.07 million in FY2022 (-78.5%) and $1.43 billion in FY2021 (-10.3%).
- The Q2 2026 figure marks the lowest quarterly EBIT since Q1 2024.
- Compared with a year earlier, EBIT was higher in three of the last seven quarters, with growth averaging 36.7%.
- The best year-over-year quarter for EBIT over five years was Q3 2024 (growth of 385.4%); the worst was Q4 2021 (a decline of 51.1%).
- Per Business Quant data, RPRX's EBIT in the three quarters before Q2 2026 was $563.04 million (Q1 2026), $388.38 million (Q4 2025) and $427.16 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Orix | 43.85 Bn | 44.35 Bn | - | 840.19 Mn |
| 2 | Rocket Companies | 43.67 Bn | 29.35 Bn | - | 655.00 Mn |
| 3 | Royalty Pharma | 33.56 Bn | 33.48 Bn | - | 133.12 Mn |
| 4 | Federal National Mortgage Association Fannie Mae | 25.52 Bn | 25.52 Bn | - | 38.30 Bn |
| 5 | Synchrony Financial | 23.24 Bn | -44.73 Bn | - | 2.16 Bn |
| 6 | Affirm Holdings | 22.66 Bn | 16.35 Bn | - | 147.26 Mn |
| 7 | Royal Gold | 20.35 Bn | 19.57 Bn | 390.45 Mn | 279.94 Mn |
| 8 | Annaly Capital Management | 15.27 Bn | 6.37 Bn | - | 2.16 Bn |
| 9 | Ares Capital | 13.74 Bn | 11.17 Bn | - | - |
| 10 | Federal Home Loan Mortgage | 12.68 Bn | -6.06 Bn | - | 33.04 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 133.12 Mn |
| Mar 31, 2026 | 563.04 Mn |
| Dec 31, 2025 | 388.38 Mn |
| Sep 30, 2025 | 427.16 Mn |
| Jun 30, 2025 | 209.80 Mn |
| Mar 31, 2025 | 534.18 Mn |
| Dec 31, 2024 | 361.51 Mn |
| Sep 30, 2024 | 735.07 Mn |
| Jun 30, 2024 | 269.63 Mn |
| Mar 31, 2024 | -73.77 Mn |
| Dec 31, 2023 | 612.90 Mn |
| Sep 30, 2023 | 151.44 Mn |
| Jun 30, 2023 | 248.84 Mn |
| Mar 31, 2023 | 478.97 Mn |
| Dec 31, 2022 | -482.66 Mn |
| Sep 30, 2022 | 192.21 Mn |
| Jun 30, 2022 | 377.79 Mn |
| Mar 31, 2022 | 219.72 Mn |
| Dec 31, 2021 | 153.42 Mn |
| Sep 30, 2021 | 303.05 Mn |
API Access
Royalty Pharma EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=RPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "RPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=RPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();